Gara Jalqabaatti › Lupus › Texas
Qorannoo klinikaalii Lupus Texas keessatti
Qorannoo 26 Lupus f Texas keessatti hirmaatuu jiru.
Magaalota Texas keessatti
- HoustonQorannoo 13
- DallasQorannoo 6
- ArlingtonQorannoo 4
- FriscoQorannoo 4
- MesquiteQorannoo 4
- AllenQorannoo 4
- San AntonioQorannoo 4
- El PasoQorannoo 4
Takkalaa qorannoo (Ingiliffa)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Allen
- Investigative Site, Arlington
- Investigative Site, Colleyville
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07260877A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50738, Bellaire
- Sl0044 50781, El Paso
- Sl0044 50673, Fort Worth
- fi 6 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Amarillo Center for Clinical Research, Amarillo
- Precision Comprehensive Clinical Research Solutions - Colleyville, Colleyville
- Precision Comprehensive Clinical Research Solutions, Euless
- fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07409181Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Prolato Clinical Research Center, Houston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05268289Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Novel Research LLC, Bellaire
- Accurate Clinical Research, League City
- Epic Medical Research, Red Oak
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, El Paso
- Research Site, Houston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05835310A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Epic Medical Research /ID# 279180, Red Oak
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07607964A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Austin
- Research Site, Baytown
- Research Site, Colleyville
- fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Amarillo Medical Specialists Rheumatology, Amarillo
- Amarillo Center for Clinical Research, Amarillo
- Arthritis and Rheumatology Research Institute, Frisco
- fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07438496Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, Allen
- Research Site, Mesquite
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07201558A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- The University of Texas Southwestern Medical Center, Dallas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 70 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07570862Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- Baylor College of Medicine, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06975787A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- North Texas Center for Clinical Research, Frisco
- Accurate Clinical Research, Humble
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07355218A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Allen Arthritis, Allen
- Arthritis and Rheumatology Research Institute PLLC, Allen
- Arthritis Care of Texas, Corpus Christi
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07332481A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Arthritis Care of Texas - Corpus Christi, Corpus Christi
- Lone Star Arthritis & Rheumatology Associates, P.C., Denton
- El Paso Medical Research Institute (MedResearch, Inc), El Paso
- fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Texas MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Texas Transplant Institute, San Antonio
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 65 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT07053800A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Integrative Rheumatology of South Texas - Harlingen /ID# 276458, Harlingen
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06977724A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Rheumatology Care Center, PLLC, Bellaire
- Texas Arthritis Center, El Paso
- Novel Research, LLC., Houston
- fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07201129A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Stryde Research, Plano
- Tranquil Clinical Research, Webster
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 05-Wax-2026 · NCT06613360A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US04-0, Irving
- US02-0, San Antonio
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT06625671Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT04751396Lupus Landmark Study: A Prospective Registry and Biorepository
- UT Southwestern Medical Center, Dallas
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT05934149Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06434363A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
- Climb Bio Investigative Site #100104, Allen
- Climb Bio Investigative Site #100101, San Antonio
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT07011043Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.